SHERI GREENE: Open Payments
NPI 1043215593 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 20 payments from 9 companies in 2025. Trend: 2023 $588 · 2024 $398 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $151 |
| PFIZER INC. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Abbott Laboratories | 1 | $14 |
Products named: VERQUVO, VYNDAQEL, LEQVIO, Kerendia, Assure WCD, CAPVAXIVE, REPATHA, LifeVest.
Industry payments across OK — which companies pay providers there.
